title: Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion model.
abstract: Mass spectrometry (MS) techniques to globally profile protein phosphorylation in cellular systems that are relevant to physiological or pathological changes have been of significant interest in biological research. An MS-based strategy utilizing an inexpensive acetone-based peptide-labeling technique known as reductive alkylation by acetone (RABA) for quantitative phosphoproteomics was explored to evaluate its capacity. Because the chemistry for RABA labeling for phosphorylation profiling had not been previously reported, it was first validated using a standard phosphoprotein and identical phosphoproteomes from cardiac tissue extracts. A workflow was then utilized to compare cardiac tissue phosphoproteomes from mouse hearts not expressing FGF2 versus hearts expressing low-molecular-weight fibroblast growth factor-2 (LMW FGF2) to relate low-molecular-weight fibroblast growth factor-2 (LMW FGF2)-mediated cardioprotective phenomena induced by ischemia/reperfusion injury of hearts, with downstream phosphorylation changes in LMW FGF2 signaling cascades. Statistically significant phosphorylation changes were identified at 14 different sites on 10 distinct proteins, including some with mechanisms already established for LMW FGF2-mediated cardioprotective signaling (e.g., connexin-43), some with new details linking LMW FGF2 to the cardioprotective mechanisms (e.g., cardiac myosin binding protein C or cMyBPC), and also several new downstream effectors not previously recognized for cardio-protective signaling by LMW FGF2. Additionally, one of the phosphopeptides, cMyBPC/pSer-282, identified was further verified with site-specific quantification using an SRM (selected reaction monitoring)-based approach that also relies on isotope labeling of a synthetic phosphopeptide with deuterated acetone as an internal standard. Overall, this study confirms that the inexpensive acetone-based peptide labeling can be used in both exploratory and targeted quantification phosphoproteomic studies to identify and verify biologically relevant phosphorylation changes in whole tissues.
authors.affiliation: Department of Cancer Biology and ‡Department of Pharmacology & Cell Biophysics, University of Cincinnati College of Medicine , 3125 Eden Avenue,Cincinnati, Ohio 45267, United States.
authors.forename: Aruna B
authors.initials: AB
authors.lastname: Wijeratne
authors.forename: Janet R
authors.initials: JR
authors.lastname: Manning
authors.forename: Jo El J
authors.initials: Jel J
authors.lastname: Schultz
authors.forename: Kenneth D
authors.initials: KD
authors.lastname: Greis
mesh_terms: D000096:Acetone / Q000737:chemistry*; D000595:Amino Acid Sequence; D000818:Animals; D002352:Carrier Proteins / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism; D002852:Chromatography, Ion Exchange; D016222:Fibroblast Growth Factor 2 / Q000235:genetics / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D015428:Myocardial Reperfusion Injury / Q000378:metabolism*; D010750:Phosphoproteins / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D020543:Proteome / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D040901:Proteomics; D015398:Signal Transduction; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013194:Staining and Labeling; D000099163:Myosin Binding Protein C
chemical_list: D000096:Acetone; D002352:Carrier Proteins; D016222:Fibroblast Growth Factor 2; D010750:Phosphoproteins; D020543:Proteome; D000099163:Myosin Binding Protein C
references.citation: Cardiovasc Res. 2003 Jan;57(1):8-19
references.pmid: 12504809
references.citation: Nat Methods. 2011 Jul 10;8(8):655-8
references.pmid: 21743459
references.citation: J Proteome Res. 2009 Nov;8(11):5375-81
references.pmid: 19761217
references.citation: Nat Protoc. 2006;1(6):2650-60
references.pmid: 17406521
references.citation: Growth Factors. 2012 Apr;30(2):124-39
references.pmid: 22304432
references.citation: J Mol Cell Cardiol. 2010 Jun;48(6):1245-54
references.pmid: 20116383
references.citation: Anal Chem. 2001 Jul 1;73(13):2836-42
references.pmid: 11467524
references.citation: Circ Res. 2011 Feb 18;108(4):490-8
references.pmid: 21335431
references.citation: Proteomics. 2011 Feb;11(4):554-70
references.pmid: 21226000
references.citation: Circ Res. 2001 Jan 19;88(1):59-62
references.pmid: 11139474
references.citation: Dev Dyn. 2009 Feb;238(2):351-7
references.pmid: 19105223
references.citation: Cell Commun Adhes. 2001;8(4-6):253-6
references.pmid: 12064598
references.citation: Proteomics. 2009 Mar;9(6):1451-68
references.pmid: 19235172
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16918-23
references.pmid: 17075052
references.citation: Nat Protoc. 2006;1(4):1929-35
references.pmid: 17487178
references.citation: J Mol Cell Cardiol. 2007 Jan;42(1):106-20
references.pmid: 17150229
references.citation: J Am Soc Mass Spectrom. 2009 Jul;20(7):1366-77
references.pmid: 19419886
references.citation: Circ Res. 2005 Nov 25;97(11):1156-63
references.pmid: 16224063
references.citation: Mol Cell Proteomics. 2011 Feb;10(2):M110.000117
references.pmid: 20495213
references.citation: Mol Cell Proteomics. 2008 Apr;7(4):661-71
references.pmid: 18039691
references.citation: Biochem Cell Biol. 2008 Apr;86(2):137-48
references.pmid: 18443627
references.citation: Annu Rev Pharmacol Toxicol. 2009;49:199-221
references.pmid: 18834307
references.citation: Biophys Rev. 2012 Jun 1;4(2):93-106
references.pmid: 22707987
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Aug;855(1):14-20
references.pmid: 17161666
references.citation: Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H2167-75
references.pmid: 16040717
references.citation: J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):285-9
references.pmid: 21821530
references.citation: Mol Cell Proteomics. 2004 Dec;3(12):1154-69
references.pmid: 15385600
references.citation: J Proteomics. 2012 Aug 3;75(15):4602-9
references.pmid: 22387130
references.citation: Anal Chem. 2003 Dec 15;75(24):6843-52
references.pmid: 14670044
references.citation: Nat Med. 1998 Feb;4(2):201-7
references.pmid: 9461194
references.citation: Nat Biotechnol. 1999 Oct;17(10):994-9
references.pmid: 10504701
references.citation: Am J Physiol Heart Circ Physiol. 2013 May 15;304(10):H1382-96
references.pmid: 23479264
references.citation: Circulation. 2003 Dec 23;108(25):3140-8
references.pmid: 14656920
references.citation: Nat Chem Biol. 2005 Oct;1(5):252-62
references.pmid: 16408053
references.citation: Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H354-65
references.pmid: 17337596